Effects of Tabletop Role-Playing Games on Nursing Students
NCT07914699, Not applicable, Completed, Kocaeli University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of Tabletop Role-Playing Games on Nursing Students | ClinicalTrials.gov |
| NCT number | NCT07914699 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 230 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Kocaeli University | ClinicalTrials.gov |
| Conditions | Social Anxiety, Self Confidence, Psychological Well-Being | ClinicalTrials.gov |
| Interventions | Tabletop Role-Playing Game Program | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Self-Confidence Total Score Measured by the Self-Confidence Scale | Baseline, month 2 (mid-intervention), and month 4 (end of intervention) | Self-confidence is measured with the Turkish Self-Confidence Scale (Akın, 2007), a 33-item self-report instrument rated on a 5-point Likert scale (1 = never, 5 = always). The total score is reported as the mean item score, ranging from 1 (minimum) to 5 (maximum); higher scores indicate greater self-confidence. | ClinicalTrials.gov |
| Secondary | Change in Social Fear/Anxiety Measured by the Liebowitz Social Anxiety Scale Fear/Anxiety Subscale | Baseline, month 2 (mid-intervention), and month 4 (end of intervention) | Social fear/anxiety is measured with the fear/anxiety subscale of the Turkish version of the Liebowitz Social Anxiety Scale (LSAS). Each of the 24 social and performance situations is rated for fear/anxiety from 0 (none) to 3 (severe). Subscale scores range from 0 (minimum) to 72 (maximum); higher scores indicate greater social fear/anxiety (worse outcome). | ClinicalTrials.gov |
| Secondary | Change in Social Avoidance Measured by the Liebowitz Social Anxiety Scale Avoidance Subscale | Baseline, month 2 (mid-intervention), and month 4 (end of intervention) | Social avoidance is measured with the avoidance subscale of the Turkish version of the Liebowitz Social Anxiety Scale (LSAS). Each of the 24 social and performance situations is rated for avoidance from 0 (never) to 3 (usually). Subscale scores range from 0 (minimum) to 72 (maximum); higher scores indicate greater social avoidance (worse outcome). | ClinicalTrials.gov |
| Secondary | Change in Mental Well-being Measured by the Warwick-Edinburgh Mental Well-being Scale (WEMWBS) | Baseline, month 2 (mid-intervention), and month 4 (end of intervention) | Mental well-being is measured with the Turkish version of the Warwick-Edinburgh Mental Well-being Scale, a 14-item self-report instrument rated on a 5-point Likert scale (1 = none of the time, 5 = all of the time). Total scores range from 14 (minimum) to 70 (maximum); higher scores indicate greater mental well-being. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)